Multiple sclerosis (MS) is generally viewed as a neuroinflammatory disease initiated by a CD4+ T cell led autoimmune attack on the central nervous system (CNS), culminating into inflammation and tissue injury (Sospedra and Martin, 2005). This evidence concerns the gene CD4 and myeloid sarcoma.